Pittsburgh Cure Sarcoma
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2020 | 153,000 | 77,432 | 75,568 | 12.5 | — |
| 2021 | 229,229 | 83,553 | 145,676 | 32.5 | 0% |
| 2022 | 338,460 | 305,496 | 32,964 | 10.2 | 0% |
| 2023 | 294,066 | 357,416 | −63,350 | 6.6 | 0% |
In its most recent public year (2023), this organization spent $63,350 more than it brought in. Its reserves stood at about 6.6 months of spending, down from 12.5 in 2020. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Pittsburgh Cure Sarcoma's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works